MARKET

BNTC

BNTC

Benitec Biopharm
NASDAQ
11.98
-0.98
-7.56%
After Hours: 11.98 0 0.00% 17:54 12/12 EST
OPEN
13.03
PREV CLOSE
12.96
HIGH
13.03
LOW
11.92
VOLUME
234.31K
TURNOVER
--
52 WEEK HIGH
17.15
52 WEEK LOW
9.70
MARKET CAP
405.67M
P/E (TTM)
-10.1200
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BNTC last week (1201-1205)?
Weekly Report · 6d ago
Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know
NASDAQ · 12/05 14:55
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting
TipRanks · 12/02 22:48
Benitec Biopharma Inc. held annual stockholder meeting
Reuters · 12/02 22:28
Weekly Report: what happened at BNTC last week (1124-1128)?
Weekly Report · 12/01 10:02
Benitec Biopharma Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 11/24 13:16
Benitec Biopharma Price Target Cut to $32.00/Share From $35.00 by HC Wainwright & Co.
Dow Jones · 11/24 13:16
HC Wainwright & Co. Maintains Buy on Benitec Biopharma, Lowers Price Target to $32
Benzinga · 11/24 13:06
More
About BNTC
Benitec Biopharma Inc is a clinical-stage biotechnology company. The Company is focused on the advancement of novel genetic medicines. Its proprietary Silence and Replace deoxyribonucleic acid (DNA) -directed ribonucleic acid (RNA) interference platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics (BB-301) for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to silence the expression of disease-causing genes (to slow, or halt, the underlying mechanism of disease progression) and to simultaneously replace the mutant genes with normal, wildtype genes.

Webull offers Benitec Biopharma Inc stock information, including NASDAQ: BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTC stock methods without spending real money on the virtual paper trading platform.